Navigation Links
Arbor Vita and WRAIR sign CRADA for traumatic brain injury collaboration
Date:9/8/2008

Sunnyvale, CA September 8, 2008 The U.S. Department of Applied Neurobiology at the Walter Reed Army Institute of Research (WRAIR) and Arbor Vita Corporation (AVC) have signed a Cooperative Research and Development Agreement (CRADA) for research and development of treatments for traumatic brain injury (TBI). The alliance is based on discoveries made from a collaborative effort between AVC and NoNO Inc., of Toronto, Canada, and will explore the use of the companies' NA-1 compound as a novel neuroprotective agent for severe brain injury of soldiers and civilians injured in explosions such as roadside bombs. NA-1 is an investigational compound that targets a PDZ protein and is in clinical trials for the treatment of stroke.

Arbor Vita Corporation has a novel drug development strategy targeting the PDZ family of proteins critical elements that organize and regulate many signaling pathways in cells. The disruption of PDZ interactions provides a means to control specific signaling cascades in complex diseases, including that which controls the death of neurons in the brain following a stroke. The combined research approach of WRAIR brain trauma scientists and neuroprotection experts and the neuroscience research teams of AVC and NoNO Inc. will provide a unique opportunity for conducting advanced preclinical neuroprotection research in a model of brain injury that mimics some types of battlefield injuries. The ultimate goal of the program is the advanced development of a novel therapy for the acute treatment of brain injury.

Traumatic brain injuries from bombs and other explosions are troubling consequences of modern urban and terrorist warfare for both military personnel and civilians. Every year, approximately 1,400,000 individuals in the U.S. and upwards of 2,000,000 worldwide experience traumatic brain injuries. To date, despite very encouraging preclinical results, almost all Phase II/III neuroprotection clinical trials for stroke and TBI
'/>"/>

Contact: Debra Bannister
debra.bannister@arborvita.com
530-676-8001
Arbor Vita Corporation
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Heavy metal link to mutations, low growth and fertility among crustaceans in Sydney Harbor tributary
2. Shipwrecks on coral reefs harbor unwanted species
3. Cold Spring Harbor Protocols highlights gene silencing, cancer cell biology methods
4. A field guide to the landscape of Cold Spring Harbor Laboratory
5. Watson-inspired innovation in research at Cold Spring Harbor Laboratory
6. Cold Spring Harbor Protocols features methods for analyzing genomes and plant cells
7. Cold Spring Harbor Protocols features classic approaches for analyzing chromosomes
8. Ugandan monkeys harbor evidence of infection with unknown poxvirus
9. Sydney harbors deadly diet for sea creatures
10. Cold Spring Harbor Laboratory scientists devise potential approach to treat spinal muscular atrophy
11. Cold Spring Harbor Protocols features methods to screen genomes and analyze evolution
Post Your Comments:
*Name:
*Comment:
*Email: